How likely is it to test positive for a pathogenic variant with GeneMate®?

28-04-2023

Among those who underwent testing with GeneMate®, 8% tested positive for a pathogenic variant. Of those who tested positive, 35% had a known pathogenic variant in the family. For the rest the information was new.

New guidelines for hereditary breast cancer

14-09-2022

Revised clinical guidelines for breast cancer were published May 10, 2022, with significant changes.

Monogenic vs Polygenic Inheritance

28-07-2022

Monogenic inheritance means that a disease is caused by a pathogenic genetic variant in a single gene. These variants, as well as the diseases or syndromes they cause, are rare in the general population.

Is blood cancer hereditary?

22-07-2022

Cancers in the blood cells, bone marrow (where blood cells are made), or lymphatic system are together called blood cancers.

Finally Kristina was able to get tested

29-06-2022

When Kristina was just 13 years old, her mom was diagnosed with breast cancer. Her maternal grandmother had lost her battle with breast cancer a few years prior

iCellate launches collaboration with football player Olivia Schough

25-04-2022

Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough.

Project ELEVATE initiates clinical trial for development of novel cancer diagnostics

22-02-2022

Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that the clinical trial for their joint project ELEVATE

Which genetic variants cause disease?

10-02-2022

While writing about genetic variants we use the terms benign, pathogenic, and variant of unknown significance (VUS).

Calculate your risk

12-01-2022

What is the likelihood that you carry a pathogenic variant?

Mapping your family cancer history

23-11-2021

The importance of family cancer history and how to map it

Hereditary stomach cancer

08-07-2021

Stomach cancer is the fifth most common cancer in the world, and 10-20% is hereditary

What to expect from your GeneMate® test

17-06-2021

In this blog post we will walk you through the various possible outcomes of your GeneMate® test.

Behind the scenes of GeneMate®

10-06-2021

Ever wonder what happens to your saliva sample after returning it to iCellate's lab?

The importance of informing family members of a positive result

17-05-2021

All first-degree relatives of a carrier have a 50% risk of themselves being a carrier

Hereditary melanoma

06-05-2021

Melanoma is the most rapidly increasing cancer in Sweden and 10-15% of all cases are hereditary

Which genes does GeneMate® test and why?

03-05-2021

Our clinically actionable selection of genes gives you a better shot at prevention.

Hereditary prostate cancer

27-04-2021

1 in 5 Swedish men will be diagnosed with prostate cancer. Guidelines for the identification of hereditary prostate cancer are now expanded.

Hereditary cancer: 97% of all carriers remain unidentified

23-04-2021

Family history-based testing identifies some, misses many

Polyposis syndromes

15-04-2021

Polyposis' cause, associated cancer types, and risk-reducing measures

iCellate’s lab receives ISO 15189 certification by Swedac

13-04-2021

iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.

Hereditary ovarian cancer

03-03-2021

15-20% of all ovarian cancer is hereditary

Lynch Syndrome

24-02-2021

Lynch syndrom is caused by hereditary pathogenic variants and increases the risk of several different cancer types

Things to consider prior to genetic testing

15-02-2021

There may be several reasons you wish to take a genetic test.

Hereditary breast cancer

03-02-2021

15-20% of all breast cancer is hereditary

Hereditary colorectal cancer

01-12-2020

One third of all colorectal cancer is hereditary